Contrasting Marrone Bio Innovations (MBII) and Calyxt (CLXT)

Marrone Bio Innovations (NASDAQ: MBII) and Calyxt (NASDAQ:CLXT) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Insider & Institutional Ownership

How to Become a New Pot Stock Millionaire

11.5% of Marrone Bio Innovations shares are owned by institutional investors. Comparatively, 22.1% of Calyxt shares are owned by institutional investors. 2.8% of Marrone Bio Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Marrone Bio Innovations and Calyxt, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marrone Bio Innovations 0 2 1 0 2.33
Calyxt 0 1 4 0 2.80

Marrone Bio Innovations currently has a consensus target price of $2.18, indicating a potential upside of 26.94%. Calyxt has a consensus target price of $29.05, indicating a potential upside of 74.58%. Given Calyxt’s stronger consensus rating and higher probable upside, analysts plainly believe Calyxt is more favorable than Marrone Bio Innovations.

Earnings & Valuation

This table compares Marrone Bio Innovations and Calyxt’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Marrone Bio Innovations $18.17 million 9.66 -$30.92 million ($1.07) -1.61
Calyxt $510,000.00 915.53 -$25.98 million ($1.12) -14.86

Calyxt has lower revenue, but higher earnings than Marrone Bio Innovations. Calyxt is trading at a lower price-to-earnings ratio than Marrone Bio Innovations, indicating that it is currently the more affordable of the two stocks.


This table compares Marrone Bio Innovations and Calyxt’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Marrone Bio Innovations -172.11% N/A -75.74%
Calyxt -5,164.61% -75.53% -57.81%


Calyxt beats Marrone Bio Innovations on 7 of the 12 factors compared between the two stocks.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The company's products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants. It also provides Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies; and Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. In addition, the company offers Haven, an anti-transpirant plant health product that reduces plant stress and dehydration; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. Marrone Bio Innovations, Inc. provides its products directly, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.

About Calyxt

Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with's FREE daily email newsletter.

Leave a Reply